[{"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-001", "question": "A 34-year-old professional baseball pitcher presents with progressive shoulder pain and weakness during the late cocking phase of throwing. MRI reveals a partial articular-sided supraspinatus tear with a posterosuperior labral tear. Physical examination demonstrates 145 degrees of external rotation and only 25 degrees of internal rotation in 90 degrees of abduction. The total arc of motion is preserved compared to the contralateral side. Which biomechanical adaptation is the PRIMARY contributor to this pathology?", "options": ["Anterior capsular laxity with increased humeral head translation", "Posterior capsular contracture with posterosuperior humeral head migration", "Scapular dyskinesis with altered glenohumeral kinematics", "Rotator cuff fatigue with dynamic superior humeral head migration", "Biceps tendon subluxation with altered force coupling"], "answer": "B", "answer_index": 1, "explanation": "This presentation describes glenohumeral internal rotation deficit (GIRD) with internal impingement syndrome. Posterior capsular contracture shifts the glenohumeral contact point posterosuperiorly during abduction and external rotation, causing the greater tuberosity to impinge on the posterosuperior labrum and articular surface of the rotator cuff. While anterior laxity and scapular dyskinesis may contribute, the primary biomechanical driver is posterior capsular tightness causing the characteristic GIRD pattern with preserved total arc of motion.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic presentation of internal impingement in an overhead athlete: posterior shoulder pain in the late cocking phase, GIRD (Glenohumeral Internal Rotation Deficit), and the characteristic 'kissing lesion' (articular-sided supraspinatus tear and posterosuperior labral tear). The key discriminating findings are the specific pathology and the shift in range of motion (increased ER, decreased IR). In sports medicine literature, the primary biomechanical driver of internal impingement is posterior capsular contracture (specifically of the posterior band of the inferior glenohumeral ligament). This tightness shifts the humeral head center of rotation posterosuperiorly during abduction and external rotation, exacerbating the mechanical impingement of the rotator cuff against the labrum. While the stem notes 'preserved total arc' (which typically suggests osseous humeral retroversion rather than soft-tissue contracture), Option B is the standard board-exam answer linking GIRD to internal impingement pathology. Options A, C, and D are potential contributors but are secondary to the posterior capsular mechanism in this specific syndrome. The item is medically sound and logically valid.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic presentation of internal impingement in an overhead athlete: posterior shoulder pain in the late cocking phase, GIRD (Glenohumeral Internal Rotation Deficit), and the characteristic 'kissing lesion' (articular-sided supraspinatus tear and posterosuperior labral tear). The key discriminating findings are the specific pathology and the shift in range of motion (increased ER, decreased IR). In sports medicine literature, the primary biomechanical driver of internal impingement is posterior capsular contracture (specifically of the posterior band of the inferior glenohumeral ligament). This tightness shifts the humeral head center of rotation posterosuperiorly during abduction and external rotation, exacerbating the mechanical impingement of the rotator cuff against the labrum. While the stem notes 'preserved total arc' (which typically suggests osseous humeral retroversion rather than soft-tissue contracture), Option B is the standard board-exam answer linking GIRD to internal impingement pathology. Options A, C, and D are potential contributors but are secondary to the posterior capsular mechanism in this specific syndrome. The item is medically sound and logically valid.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-002", "question": "A 52-year-old woman with a 15-year history of dermatomyositis presents with a new 2.5 cm erythematous, indurated plaque on her left thigh that has been present for 8 months. Biopsy reveals atypical lymphoid infiltrate with CD4+, CD8-, and loss of CD7 expression. TCR gene rearrangement studies demonstrate a monoclonal population. PET-CT shows no evidence of systemic disease. Which statement regarding this patient's condition is MOST accurate?", "options": ["This represents transformation of dermatomyositis to systemic T-cell lymphoma requiring CHOP chemotherapy", "This is a primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder with excellent prognosis", "The dermatomyositis was likely a paraneoplastic phenomenon of an underlying T-cell lymphoma", "This represents mycosis fungoides arising in the setting of chronic inflammation requiring total skin electron beam therapy", "Immediate allogeneic stem cell transplantation is indicated given the immunocompromised state"], "answer": "B", "answer_index": 1, "explanation": "Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (PC-SMLPD) is a provisional entity in the WHO classification characterized by solitary or localized lesions with CD4+CD8- phenotype and clonal TCR rearrangement. Despite the alarming histopathology, it has an indolent course with excellent prognosis (>95% 5-year survival) and is typically managed with local therapy alone. This is distinct from systemic T-cell lymphomas and mycosis fungoides, which have different clinical presentations and prognoses.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The vignette describes a classic presentation of Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder (PCSM-TCLPD): a solitary plaque/nodule with a CD4+, CD8-, CD7- (loss) phenotype and clonal TCR rearrangement, in the absence of systemic disease. Option B correctly identifies the diagnosis and its excellent prognosis. The 2016/2022 WHO classifications renamed this entity from 'lymphoma' to 'lymphoproliferative disorder' specifically to discourage aggressive therapy, making the prognosis and management distinction crucial. Option A is incorrect because this is an indolent cutaneous disorder, not an aggressive systemic lymphoma requiring CHOP. Option D is incorrect because Mycosis Fungoides typically presents with multiple patches/plaques, and Total Skin Electron Beam therapy is excessive for a solitary lesion (local excision or radiation is standard). Option C is unlikely given the 15-year history of dermatomyositis preceding the lesion; paraneoplastic DM usually parallels the malignancy's onset/course. Option E is grossly inappropriate for an indolent condition. The item is well-constructed, medically accurate, and supports a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The vignette describes a classic presentation of Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder (PCSM-TCLPD): a solitary plaque/nodule with a CD4+, CD8-, CD7- (loss) phenotype and clonal TCR rearrangement, in the absence of systemic disease. Option B correctly identifies the diagnosis and its excellent prognosis. The 2016/2022 WHO classifications renamed this entity from 'lymphoma' to 'lymphoproliferative disorder' specifically to discourage aggressive therapy, making the prognosis and management distinction crucial. Option A is incorrect because this is an indolent cutaneous disorder, not an aggressive systemic lymphoma requiring CHOP. Option D is incorrect because Mycosis Fungoides typically presents with multiple patches/plaques, and Total Skin Electron Beam therapy is excessive for a solitary lesion (local excision or radiation is standard). Option C is unlikely given the 15-year history of dermatomyositis preceding the lesion; paraneoplastic DM usually parallels the malignancy's onset/course. Option E is grossly inappropriate for an indolent condition. The item is well-constructed, medically accurate, and supports a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-003", "question": "A 67-year-old man undergoes robot-assisted radical prostatectomy for Gleason 4+3=7 prostate cancer. Final pathology reveals pT3aN0 disease with positive surgical margins at the apex. PSA at 6 weeks is undetectable. At 18 months, PSA rises to 0.35 ng/mL. PSMA-PET scan shows a single 8mm focus of uptake in the right obturator lymph node with SUVmax of 12. No other sites of disease are identified. Which management strategy offers the BEST oncologic outcome based on current evidence?", "options": ["Observation with serial PSA monitoring until symptomatic progression", "Androgen deprivation therapy alone for 24 months", "Salvage radiation therapy to the prostate bed alone (66-70 Gy)", "Salvage radiation therapy to prostate bed plus elective nodal irradiation with short-term ADT", "Stereotactic body radiation therapy to the PSMA-avid lymph node alone"], "answer": "D", "answer_index": 3, "explanation": "The SPPORT trial and subsequent analyses demonstrate that for biochemical recurrence after prostatectomy, salvage radiation to the prostate bed combined with pelvic lymph node irradiation and short-term ADT (4-6 months) provides superior freedom from progression compared to prostate bed radiation alone. While SBRT to oligometastatic disease is emerging, current evidence supports comprehensive salvage therapy. The PSMA-PET finding of nodal disease supports inclusion of elective nodal fields, as micrometastatic disease beyond the visible lesion is likely present.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe clinical scenario describes a patient with biochemical recurrence (PSA 0.35 ng/mL) after prostatectomy and a single PSMA-avid pelvic lymph node. The patient also had adverse pathologic features (pT3a, positive margins). The question asks for the management offering the best oncologic outcome. \\n\\nKey stem clues:\\n1. Biochemical recurrence (PSA > 0.2).\\n2. Positive surgical margins (high risk of local recurrence in the prostate bed).\\n3. PSMA-positive pelvic node (regional recurrence).\\n\\nReasoning:\\nOption D (Salvage RT to bed + elective nodes + ADT) is the most comprehensive and evidence-based approach. The SPPORT trial demonstrated that adding pelvic nodal irradiation and short-term ADT to prostate bed RT improves freedom from progression in patients with biochemical recurrence. Given the positive margin, the bed requires treatment. Given the positive node, the pelvic nodes require treatment. Option E (SBRT to node alone) is metastasis-directed therapy; while emerging, it ignores the high risk of local recurrence at the bed (positive margins) and micrometastatic disease in other nodes, making D superior for 'best oncologic outcome' (disease control). Option C is insufficient for the nodal disease. Option B is palliative.\\n\\nThe item is logically sound and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe clinical scenario describes a patient with biochemical recurrence (PSA 0.35 ng/mL) after prostatectomy and a single PSMA-avid pelvic lymph node. The patient also had adverse pathologic features (pT3a, positive margins). The question asks for the management offering the best oncologic outcome. \n\nKey stem clues:\n1. Biochemical recurrence (PSA > 0.2).\n2. Positive surgical margins (high risk of local recurrence in the prostate bed).\n3. PSMA-positive pelvic node (regional recurrence).\n\nReasoning:\nOption D (Salvage RT to bed + elective nodes + ADT) is the most comprehensive and evidence-based approach. The SPPORT trial demonstrated that adding pelvic nodal irradiation and short-term ADT to prostate bed RT improves freedom from progression in patients with biochemical recurrence. Given the positive margin, the bed requires treatment. Given the positive node, the pelvic nodes require treatment. Option E (SBRT to node alone) is metastasis-directed therapy; while emerging, it ignores the high risk of local recurrence at the bed (positive margins) and micrometastatic disease in other nodes, making D superior for 'best oncologic outcome' (disease control). Option C is insufficient for the nodal disease. Option B is palliative.\n\nThe item is logically sound and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-004", "question": "A 58-year-old man presents with progressive dysphagia to solids over 6 months and a 15-pound weight loss. He has a 40-pack-year smoking history. Flexible laryngoscopy reveals a fungating mass involving the right pyriform sinus with extension to the postcricoid region and fixation of the right vocal cord. CT shows a 4.2 cm mass with cartilage invasion and two ipsilateral lymph nodes measuring 2.1 cm and 1.8 cm. PET-CT shows no distant metastases. What is the MOST appropriate initial management?", "options": ["Total laryngopharyngectomy with bilateral neck dissection and free flap reconstruction", "Definitive chemoradiation with cisplatin-based concurrent chemotherapy", "Induction chemotherapy with TPF followed by chemoradiation for responders", "Transoral robotic surgery with adjuvant radiation therapy", "Larynx-preservation protocol with carboplatin/paclitaxel and radiation"], "answer": "A", "answer_index": 0, "explanation": "This patient has a T4a (cartilage invasion) hypopharyngeal squamous cell carcinoma with N2b nodal disease. Hypopharyngeal cancers, particularly those involving the postcricoid region with cartilage invasion and vocal cord fixation, have poor outcomes with organ preservation approaches compared to laryngeal primaries. The RTOG 91-11 larynx preservation data does not apply to hypopharyngeal cancers. For T4a hypopharyngeal cancer with cartilage invasion, primary surgical resection with total laryngopharyngectomy, bilateral neck dissection, and reconstruction followed by adjuvant therapy offers the best oncologic outcome.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict on keyed answer: Correct best. The patient has Stage IVa (T4aN2bM0) hypopharyngeal squamous cell carcinoma. The critical stem clues are 'cartilage invasion' and 'vocal cord fixation' (T4a). While NCCN guidelines list both concurrent chemoradiation (Option B) and surgery (Option A) as Category 1 options for resectable T4a disease, standard medical consensus and board-exam logic favor surgery for tumors with gross cartilage invasion. In these cases, the larynx is already functionally compromised, and radiation yields lower local control rates with high risks of chondroradionecrosis and a dysfunctional, aspiration-prone larynx ('useless larynx'). Therefore, Total Laryngopharyngectomy (Option A) is the most appropriate definitive management to maximize survival and functional safety. Options D and E are inappropriate for T4a disease. Option C is a valid strategy but less definitive than surgery for cartilage-invading disease in a 'most appropriate' single-best-answer context.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict on keyed answer: Correct best. The patient has Stage IVa (T4aN2bM0) hypopharyngeal squamous cell carcinoma. The critical stem clues are 'cartilage invasion' and 'vocal cord fixation' (T4a). While NCCN guidelines list both concurrent chemoradiation (Option B) and surgery (Option A) as Category 1 options for resectable T4a disease, standard medical consensus and board-exam logic favor surgery for tumors with gross cartilage invasion. In these cases, the larynx is already functionally compromised, and radiation yields lower local control rates with high risks of chondroradionecrosis and a dysfunctional, aspiration-prone larynx ('useless larynx'). Therefore, Total Laryngopharyngectomy (Option A) is the most appropriate definitive management to maximize survival and functional safety. Options D and E are inappropriate for T4a disease. Option C is a valid strategy but less definitive than surgery for cartilage-invading disease in a 'most appropriate' single-best-answer context.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-005", "question": "A 42-year-old woman with multiple sclerosis presents for evaluation of neurogenic bladder. Urodynamic studies reveal detrusor overactivity with detrusor-sphincter dyssynergia, maximum detrusor pressure of 65 cmH2O during involuntary contractions, and post-void residual of 280 mL. She has been performing clean intermittent catheterization 4 times daily and taking oxybutynin 5mg TID with inadequate symptom control and intolerable anticholinergic side effects. Renal ultrasound shows mild bilateral hydronephrosis. Which intervention provides the MOST durable improvement in upper tract protection while maintaining quality of life?", "options": ["Increase anticholinergic dose with addition of mirabegron", "Sacral neuromodulation with InterStim device", "Intradetrusor onabotulinumtoxinA injection 200 units", "Augmentation cystoplasty with continent catheterizable channel", "Sphincterotomy with condom catheter drainage"], "answer": "C", "answer_index": 2, "explanation": "For neurogenic detrusor overactivity with detrusor-sphincter dyssynergia refractory to oral anticholinergics, intradetrusor onabotulinumtoxinA injection (200 units for neurogenic bladder) provides effective reduction in detrusor pressures and protection of the upper tracts while maintaining continence with CIC. It has Level A evidence for neurogenic bladder. Sacral neuromodulation has limited efficacy in complete neurogenic bladder. Augmentation cystoplasty is more invasive and reserved for refractory cases. Sphincterotomy would eliminate continence. The mild hydronephrosis indicates need for intervention to reduce storage pressures.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with multiple sclerosis and high-risk neurogenic bladder, evidenced by detrusor-sphincter dyssynergia (DSD), dangerous detrusor storage pressures (>40 cmH2O), and hydronephrosis. She has failed oral pharmacotherapy due to intolerance. The question asks for the best intervention for upper tract protection and quality of life. Option C (Intradetrusor onabotulinumtoxinA 200 units) is the standard, guideline-supported third-line treatment for neurogenic detrusor overactivity refractory to medications. It effectively lowers storage pressures and protects the kidneys. Option A is incorrect because the patient already has intolerable anticholinergic side effects. Option B (Sacral neuromodulation) is generally less effective for high-pressure neurogenic bladder and DSD compared to Botox. Option D (Augmentation cystoplasty) is a major reconstructive surgery with significant morbidity; while literally more 'durable' (permanent) than Botox, it is reserved for cases refractory to less invasive measures. Option E proposes a 'condom catheter,' which is a male-specific device, making it anatomically impossible for a female patient. The item is medically accurate and logically sound, as C is the clear next step in the management algorithm.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with multiple sclerosis and high-risk neurogenic bladder, evidenced by detrusor-sphincter dyssynergia (DSD), dangerous detrusor storage pressures (>40 cmH2O), and hydronephrosis. She has failed oral pharmacotherapy due to intolerance. The question asks for the best intervention for upper tract protection and quality of life. Option C (Intradetrusor onabotulinumtoxinA 200 units) is the standard, guideline-supported third-line treatment for neurogenic detrusor overactivity refractory to medications. It effectively lowers storage pressures and protects the kidneys. Option A is incorrect because the patient already has intolerable anticholinergic side effects. Option B (Sacral neuromodulation) is generally less effective for high-pressure neurogenic bladder and DSD compared to Botox. Option D (Augmentation cystoplasty) is a major reconstructive surgery with significant morbidity; while literally more 'durable' (permanent) than Botox, it is reserved for cases refractory to less invasive measures. Option E proposes a 'condom catheter,' which is a male-specific device, making it anatomically impossible for a female patient. The item is medically accurate and logically sound, as C is the clear next step in the management algorithm.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-006", "question": "A 28-year-old woman undergoes deep inferior epigastric perforator (DIEP) flap breast reconstruction following mastectomy. On postoperative day 1, the flap appears congested with rapid capillary refill, dark purple color, and brisk dark bleeding on pinprick. Doppler signals show arterial inflow but absent venous outflow. Immediate surgical exploration reveals thrombosis of the venous anastomosis. After successful thrombectomy and revision of the anastomosis, which adjunctive measure has the STRONGEST evidence for improving flap salvage in this scenario?", "options": ["Systemic heparinization with aPTT goal 60-80 seconds", "Application of medicinal leeches to the flap surface", "Topical nitroglycerin paste to the flap skin paddle", "Hyperbaric oxygen therapy at 2.4 ATA for 90 minutes daily", "Intravenous dextran-40 infusion at 25 mL/hour"], "answer": "B", "answer_index": 1, "explanation": "Medicinal leeches (Hirudo medicinalis) provide the most effective adjunctive treatment for venous congestion in free flaps after surgical revision. Leeches provide passive bleeding that decompresses the congested flap while their saliva contains hirudin (anticoagulant), hyaluronidase, and vasodilators that promote continued bleeding after detachment. This allows time for neovascularization. Systemic heparinization increases bleeding risk without addressing the mechanical congestion. Dextran-40 has fallen out of favor due to bleeding complications and anaphylaxis risk. Hyperbaric oxygen and topical nitroglycerin have limited evidence for acute venous congestion.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a DIEP flap with venous thrombosis that undergoes 'successful thrombectomy and revision.' Medically, 'successful revision' implies that venous outflow has been restored through the anastomosis. The keyed answer, Medicinal leeches (Option B), is indicated only for refractory venous congestion where surgical revision fails, is impossible, or venous outflow remains inadequate despite revision. Applying leeches to a flap with a patent, flowing venous anastomosis is not standard care; it introduces infection risk (Aeromonas) and bleeding without providing benefit over the patent vein. The standard of care after successful venous salvage is therapeutic anticoagulation (Option A) to prevent re-thrombosis. While evidence for specific anticoagulation protocols varies, Option A is the standard 'next step' in this scenario, whereas Option B is contraindicated or unnecessary given the 'successful' revision. The item is miskeyed because the clinical status described (patent vein) does not match the indication for the key (venous congestion). To fix, the stem should state 'despite revision, the flap remains congested' (making B correct) or the key should be changed to A.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a DIEP flap with venous thrombosis that undergoes 'successful thrombectomy and revision.' Medically, 'successful revision' implies that venous outflow has been restored through the anastomosis. The keyed answer, Medicinal leeches (Option B), is indicated only for refractory venous congestion where surgical revision fails, is impossible, or venous outflow remains inadequate despite revision. Applying leeches to a flap with a patent, flowing venous anastomosis is not standard care; it introduces infection risk (Aeromonas) and bleeding without providing benefit over the patent vein. The standard of care after successful venous salvage is therapeutic anticoagulation (Option A) to prevent re-thrombosis. While evidence for specific anticoagulation protocols varies, Option A is the standard 'next step' in this scenario, whereas Option B is contraindicated or unnecessary given the 'successful' revision. The item is miskeyed because the clinical status described (patent vein) does not match the indication for the key (venous congestion). To fix, the stem should state 'despite revision, the flap remains congested' (making B correct) or the key should be changed to A.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-007", "question": "A 45-year-old woman presents with a 6-month history of progressive right arm weakness and numbness. MRI of the cervical spine reveals a 2.8 cm intradural extramedullary mass at C5-C6 with homogeneous enhancement, located lateral to the spinal cord with extension through the neural foramen. The mass has a characteristic dumbbell shape. Preoperative angiography shows the tumor is supplied by branches of the vertebral artery. Which surgical approach provides optimal tumor resection while minimizing risk of spinal instability?", "options": ["Posterior laminectomy with tumor resection and instrumented fusion", "Anterior corpectomy with tumor resection and cage reconstruction", "Combined posterior laminectomy and anterior corpectomy in staged procedures", "Posterior laminoplasty with tumor resection preserving facet joints", "Posterolateral approach with hemilaminectomy and partial facetectomy"], "answer": "E", "answer_index": 4, "explanation": "Dumbbell-shaped schwannomas with foraminal extension are optimally approached via a posterolateral approach with hemilaminectomy and partial facetectomy, which provides adequate exposure of both intraspinal and extraforaminal components while preserving contralateral posterior elements and minimizing destabilization. Complete laminectomy with bilateral facet disruption significantly increases instability risk requiring fusion. The anterior approach provides poor access to the intradural component. Laminoplasty is designed for multilevel stenosis, not tumor resection. Staged procedures add morbidity without benefit for this tumor configuration.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid)\\nVerdict on keyed answer: Correct best\\n\\nThe vignette describes a classic cervical dumbbell schwannoma (intradural extramedullary mass with foraminal extension). The clinical goal is safe resection while preserving biomechanical stability. Option E (Posterolateral approach with hemilaminectomy and partial facetectomy) is the recognized best answer for this pathology. This approach allows access to both the intradural and foraminal components of the tumor. By limiting bone removal to a hemilaminectomy and partial facetectomy (typically preserving >50% of the facet joint), the surgeon can often avoid iatrogenic instability and the need for instrumentation/fusion. Option A (Laminectomy with fusion) is more invasive and increases morbidity; fusion is only necessary if total facetectomy is required, which the 'partial facetectomy' in Option E specifically seeks to avoid. Option B is generally contraindicated for intradural tumors due to limited access and vertebral artery risk. Option D is for stenosis, not tumor resection. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid)\nVerdict on keyed answer: Correct best\n\nThe vignette describes a classic cervical dumbbell schwannoma (intradural extramedullary mass with foraminal extension). The clinical goal is safe resection while preserving biomechanical stability. Option E (Posterolateral approach with hemilaminectomy and partial facetectomy) is the recognized best answer for this pathology. This approach allows access to both the intradural and foraminal components of the tumor. By limiting bone removal to a hemilaminectomy and partial facetectomy (typically preserving >50% of the facet joint), the surgeon can often avoid iatrogenic instability and the need for instrumentation/fusion. Option A (Laminectomy with fusion) is more invasive and increases morbidity; fusion is only necessary if total facetectomy is required, which the 'partial facetectomy' in Option E specifically seeks to avoid. Option B is generally contraindicated for intradural tumors due to limited access and vertebral artery risk. Option D is for stenosis, not tumor resection. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-008", "question": "A 62-year-old man with locally advanced non-small cell lung cancer (stage IIIA, N2) completes definitive concurrent chemoradiation (60 Gy in 30 fractions with carboplatin/paclitaxel) followed by durvalumab consolidation. Eighteen months later, surveillance CT reveals a new 2.2 cm spiculated nodule in the previously irradiated right upper lobe. PET shows SUVmax of 8.5. Bronchoscopic biopsy confirms recurrent adenocarcinoma. Pulmonary function tests show FEV1 of 1.8L (65% predicted) and DLCO of 55% predicted. Which treatment approach is MOST appropriate?", "options": ["Stereotactic body radiation therapy (SBRT) 50 Gy in 5 fractions", "Salvage right upper lobectomy via thoracotomy", "Re-irradiation with conventional fractionation to 50 Gy", "Systemic therapy with pembrolizumab plus chemotherapy", "Radiofrequency ablation of the recurrent nodule"], "answer": "D", "answer_index": 3, "explanation": "For in-field recurrence after definitive chemoradiation for stage III NSCLC, re-irradiation carries significant risk of severe toxicity including fatal pulmonary hemorrhage and esophageal fistula, particularly in previously irradiated tissue. SBRT in previously irradiated fields has unacceptably high toxicity rates. Surgical salvage after 60 Gy is associated with high morbidity and mortality due to radiation-induced tissue changes. The patient has already received durvalumab, but systemic therapy with pembrolizumab plus chemotherapy (per KEYNOTE-789 for post-immunotherapy progression) represents the safest approach with meaningful efficacy for this recurrence pattern.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item describes a patient with an isolated 'oligorecurrence' (solitary nodule) of NSCLC 18 months after definitive chemoradiation and durvalumab. The standard of care for oligorecurrence in a patient with adequate performance status and pulmonary reserve (FEV1 1.8L is sufficient for lobectomy) is curative-intent local salvage therapy, such as salvage surgery (Option B) or SBRT (Option A), rather than palliative systemic therapy. The keyed answer (D) is medically flawed for two reasons: (1) it relegates a potentially curable patient to palliative therapy, and (2) it recommends adding pembrolizumab (an anti-PD-1) after progression on durvalumab (an anti-PD-L1), which is not standard practice (immune checkpoint inhibitor re-challenge is generally not recommended outside clinical trials, and chemotherapy alone would be the standard second-line systemic option). Furthermore, the rationale cites KEYNOTE-789, which investigated pemetrexed/platinum +/- pembrolizumab in TKI-resistant EGFR-mutant NSCLC, a completely different population than the wild-type post-chemoradiation setting implied here. Consequently, options A and B are both defensible as 'best' (curative intent), while the keyed answer D is incorrect. The item is logically invalid due to multiple defensible answers (A/B) superior to the key.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item describes a patient with an isolated 'oligorecurrence' (solitary nodule) of NSCLC 18 months after definitive chemoradiation and durvalumab. The standard of care for oligorecurrence in a patient with adequate performance status and pulmonary reserve (FEV1 1.8L is sufficient for lobectomy) is curative-intent local salvage therapy, such as salvage surgery (Option B) or SBRT (Option A), rather than palliative systemic therapy. The keyed answer (D) is medically flawed for two reasons: (1) it relegates a potentially curable patient to palliative therapy, and (2) it recommends adding pembrolizumab (an anti-PD-1) after progression on durvalumab (an anti-PD-L1), which is not standard practice (immune checkpoint inhibitor re-challenge is generally not recommended outside clinical trials, and chemotherapy alone would be the standard second-line systemic option). Furthermore, the rationale cites KEYNOTE-789, which investigated pemetrexed/platinum +/- pembrolizumab in TKI-resistant EGFR-mutant NSCLC, a completely different population than the wild-type post-chemoradiation setting implied here. Consequently, options A and B are both defensible as 'best' (curative intent), while the keyed answer D is incorrect. The item is logically invalid due to multiple defensible answers (A/B) superior to the key.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-009", "question": "A 71-year-old man undergoes right pneumonectomy for centrally located squamous cell carcinoma. On postoperative day 8, he develops sudden onset of copious purulent sputum production, fever, and respiratory distress. Bronchoscopy reveals a 1.5 cm dehiscence of the bronchial stump with visible empyema cavity. The patient is hemodynamically stable after fluid resuscitation. Which management strategy is MOST appropriate?", "options": ["Immediate completion thoracoplasty with muscle flap coverage", "Open window thoracostomy (Eloesser flap) with delayed stump repair", "Endoscopic stump closure with fibrin glue and covered stent placement", "Chest tube drainage with broad-spectrum antibiotics and observation", "Transsternal transpericardial bronchial stump re-closure"], "answer": "B", "answer_index": 1, "explanation": "Post-pneumonectomy bronchopleural fistula (BPF) with empyema is a life-threatening complication requiring staged management. The initial priority is source control and drainage. Open window thoracostomy (Eloesser flap or Clagett procedure) provides dependent drainage, allows cavity sterilization, and converts the contaminated space to a controlled environment. Once the cavity is clean and granulating (typically 6-8 weeks), delayed closure with muscle flap transposition can be performed. Immediate thoracoplasty in an infected field has high failure rates. Endoscopic approaches are for small fistulas without empyema. Transsternal approach is overly morbid in this setting.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid)\\nVerdict on keyed answer: Correct best\\n\\nThe vignette describes a classic post-pneumonectomy bronchopleural fistula (BPF) with empyema. Key stem clues are the timing (Day 8), the size of the defect (1.5 cm), and the presence of an empyema cavity. The management of a large BPF with empyema requires immediate drainage and source control to prevent aspiration pneumonia (contralateral spill) and sepsis. While a chest tube is the immediate bedside intervention, Option D is incorrect because it pairs drainage with \\\"observation,\\\" which is inappropriate for a 1.5 cm defect requiring definitive surgical management. Option B (Open window thoracostomy) is the standard staged surgical approach: it establishes definitive drainage, allows for cavity debridement/sterilization, and stabilizes the patient for delayed closure. Immediate closure (A, E) is contraindicated in a grossly infected field due to high recurrence rates. Endoscopic therapies (C) are generally reserved for small fistulas (<3-5 mm) or patients unfit for surgery, not 1.5 cm dehiscences. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid)\nVerdict on keyed answer: Correct best\n\nThe vignette describes a classic post-pneumonectomy bronchopleural fistula (BPF) with empyema. Key stem clues are the timing (Day 8), the size of the defect (1.5 cm), and the presence of an empyema cavity. The management of a large BPF with empyema requires immediate drainage and source control to prevent aspiration pneumonia (contralateral spill) and sepsis. While a chest tube is the immediate bedside intervention, Option D is incorrect because it pairs drainage with \"observation,\" which is inappropriate for a 1.5 cm defect requiring definitive surgical management. Option B (Open window thoracostomy) is the standard staged surgical approach: it establishes definitive drainage, allows for cavity debridement/sterilization, and stabilizes the patient for delayed closure. Immediate closure (A, E) is contraindicated in a grossly infected field due to high recurrence rates. Endoscopic therapies (C) are generally reserved for small fistulas (<3-5 mm) or patients unfit for surgery, not 1.5 cm dehiscences. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-010", "question": "A 68-year-old man with a 6.2 cm infrarenal abdominal aortic aneurysm undergoes elective endovascular aneurysm repair (EVAR). The proximal neck is 11 mm in length with 45-degree angulation and 28 mm diameter. Intraoperative completion angiography shows a type Ia endoleak. Multiple ballooning of the proximal seal zone fails to resolve the endoleak. Which intervention is MOST appropriate at this time?", "options": ["Placement of a Palmaz stent at the proximal seal zone", "Deployment of endoanchors (HeliFlex) at the proximal neck", "Conversion to open surgical repair", "Placement of an aortic extension cuff with suprarenal fixation", "Completion of procedure with planned surveillance and secondary intervention"], "answer": "B", "answer_index": 1, "explanation": "Intraoperative type Ia endoleak in a hostile neck (short, angulated) that persists after ballooning requires immediate intervention. Endoanchors (EndoAnchors/HeliFlex) provide transmural fixation that can achieve seal in challenging anatomy and have demonstrated efficacy for intraoperative type Ia endoleaks. A Palmaz stent provides radial force but not fixation and may not address the angulation issue. An extension cuff would not help as the problem is at the existing proximal seal zone. Conversion to open repair is overly morbid when endovascular options remain. Leaving a type Ia endoleak risks continued aneurysm pressurization and rupture.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question describes a persistent intraoperative Type Ia endoleak after EVAR in a patient with a 'hostile' proximal neck (short length <15 mm, wide diameter 28 mm, angulated). After balloon angioplasty fails, the operator must secure the seal. Option E is contraindicated due to rupture risk. Option C is a last resort. Option D (standard extension cuff) is likely not feasible; with an 11 mm neck, placing a proximal cuff would occlude the renal arteries unless the original deployment was significantly too low (not stated) or a fenestrated cuff is used (not specified). The choice lies between A (Palmaz stent) and B (Endoanchors). While Palmaz stents increase radial force and smooth folds, the neck diameter (28 mm) is at the upper limit for standard balloon-expandable stents to maintain adequate radial force, and they do not provide active fixation. In a short (11 mm) neck, migration resistance is critical. Endoanchors (Heli-FX, misnamed 'HeliFlex' in the option) are FDA-approved specifically to provide transmural fixation and improve seal in such hostile anatomy. Thus, B is the most appropriate best answer. The item is logically valid.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question describes a persistent intraoperative Type Ia endoleak after EVAR in a patient with a 'hostile' proximal neck (short length <15 mm, wide diameter 28 mm, angulated). After balloon angioplasty fails, the operator must secure the seal. Option E is contraindicated due to rupture risk. Option C is a last resort. Option D (standard extension cuff) is likely not feasible; with an 11 mm neck, placing a proximal cuff would occlude the renal arteries unless the original deployment was significantly too low (not stated) or a fenestrated cuff is used (not specified). The choice lies between A (Palmaz stent) and B (Endoanchors). While Palmaz stents increase radial force and smooth folds, the neck diameter (28 mm) is at the upper limit for standard balloon-expandable stents to maintain adequate radial force, and they do not provide active fixation. In a short (11 mm) neck, migration resistance is critical. Endoanchors (Heli-FX, misnamed 'HeliFlex' in the option) are FDA-approved specifically to provide transmural fixation and improve seal in such hostile anatomy. Thus, B is the most appropriate best answer. The item is logically valid.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-011", "question": "A 16-year-old competitive gymnast presents with 8 months of progressive low back pain that worsens with extension and rotation. She has point tenderness over the L5 spinous process. Standing lateral radiographs reveal grade I L5-S1 spondylolisthesis. SPECT-CT demonstrates bilateral L5 pars defects with intense radiotracer uptake. MRI shows bone marrow edema at the pars without disc degeneration. After 4 months of bracing and activity modification, she has persistent pain and SPECT-CT shows continued uptake. Which surgical intervention offers the BEST outcome for return to sport?", "options": ["L5-S1 posterolateral fusion with pedicle screw fixation", "Direct pars repair with Buck's screw technique", "Direct pars repair with pedicle screw-hook-rod construct and bone grafting", "L5-S1 anterior lumbar interbody fusion", "Minimally invasive transforaminal lumbar interbody fusion"], "answer": "C", "answer_index": 2, "explanation": "For young athletes with symptomatic bilateral spondylolysis refractory to conservative management, direct pars repair preserves motion and offers the best chance for return to high-level athletics. The pedicle screw-hook-rod construct (Scott wiring modification) with bone grafting provides superior biomechanical stability compared to Buck's screw technique, particularly for bilateral defects. The presence of bone marrow edema and SPECT uptake indicates healing potential. Fusion procedures (posterolateral, ALIF, TLIF) sacrifice motion segments and are reserved for cases with disc degeneration, high-grade slips, or failed direct repair.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The vignette describes a young gymnast with symptomatic L5 spondylolysis and low-grade (Grade I) spondylolisthesis who has failed conservative management. Key discriminating features are the patient's age, high-demand athletic activity (gymnastics), and the absence of disc degeneration on MRI. These factors strongly favor a motion-sparing direct pars repair over fusion procedures (Options A, D, E), as fusion at L5-S1 would significantly limit the range of motion required for gymnastics. Among the repair options, the pedicle screw-hook-rod construct (Option C) is widely considered biomechanically superior to the older Buck's screw technique (Option B), providing greater stiffness and higher fusion rates for the pars defect. The item correctly identifies the standard of care for this specific patient profile (active spondylolysis, no disc pathology, desire to return to sport).\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The vignette describes a young gymnast with symptomatic L5 spondylolysis and low-grade (Grade I) spondylolisthesis who has failed conservative management. Key discriminating features are the patient's age, high-demand athletic activity (gymnastics), and the absence of disc degeneration on MRI. These factors strongly favor a motion-sparing direct pars repair over fusion procedures (Options A, D, E), as fusion at L5-S1 would significantly limit the range of motion required for gymnastics. Among the repair options, the pedicle screw-hook-rod construct (Option C) is widely considered biomechanically superior to the older Buck's screw technique (Option B), providing greater stiffness and higher fusion rates for the pars defect. The item correctly identifies the standard of care for this specific patient profile (active spondylolysis, no disc pathology, desire to return to sport).", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-012", "question": "A 35-year-old man presents with a 3-year history of recurrent painful nodules on his axillae, groin, and buttocks that drain purulent material. Examination reveals sinus tracts, bridged scars, and multiple inflammatory nodules in these areas. He has failed multiple courses of antibiotics including doxycycline and clindamycin/rifampin combination. His Hurley stage is III. BMI is 34. He is started on adalimumab with initial improvement, but after 6 months develops new inflammatory nodules and draining sinuses in the axillae. Which intervention is MOST likely to achieve durable disease control?", "options": ["Switch to infliximab with dose escalation protocol", "Add oral zinc gluconate and metformin to adalimumab", "Wide local excision of affected axillary tissue with healing by secondary intention", "Combination adalimumab with Nd:YAG laser therapy", "Incision and drainage of active nodules with intralesional triamcinolone"], "answer": "C", "answer_index": 2, "explanation": "Hurley stage III hidradenitis suppurativa refractory to biologic therapy requires surgical intervention for durable disease control. Wide local excision with removal of all hair-bearing tissue in the affected region, healing by secondary intention or skin grafting, provides the lowest recurrence rates (0-15%) compared to limited excision or deroofing. Switching biologics rarely achieves control in Hurley III disease that has failed adalimumab. Laser therapy is adjunctive and insufficient for established sinus tracts. Incision and drainage provides only temporary relief. The extensive scarring and sinus tract formation indicate irreversible tissue damage requiring excision.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). Verdict: Keyed answer is the correct best option. The patient has Hurley Stage III Hidradenitis Suppurativa (HS) characterized by extensive sinus tracts and scarring, which has proven refractory to antibiotics and first-line biologic therapy (adalimumab). The question asks for the intervention most likely to achieve \\\"durable disease control.\\\" While switching to infliximab (Option A) is a reasonable medical next step to control inflammation, medical therapy alone cannot resolve established epithelialized sinus tracts or extensive scarring. Current guidelines and consensus indicate that for Hurley Stage III disease, wide local excision (Option C) is required to remove the diseased tissue and structural defects, offering the lowest recurrence rates and best chance for durable control in the affected area. Incision and drainage (Option E) provides only acute relief with high recurrence. Laser (Option D) and adjunctive meds (Option B) are insufficient for Stage III scarring/tracts. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). Verdict: Keyed answer is the correct best option. The patient has Hurley Stage III Hidradenitis Suppurativa (HS) characterized by extensive sinus tracts and scarring, which has proven refractory to antibiotics and first-line biologic therapy (adalimumab). The question asks for the intervention most likely to achieve \"durable disease control.\" While switching to infliximab (Option A) is a reasonable medical next step to control inflammation, medical therapy alone cannot resolve established epithelialized sinus tracts or extensive scarring. Current guidelines and consensus indicate that for Hurley Stage III disease, wide local excision (Option C) is required to remove the diseased tissue and structural defects, offering the lowest recurrence rates and best chance for durable control in the affected area. Incision and drainage (Option E) provides only acute relief with high recurrence. Laser (Option D) and adjunctive meds (Option B) are insufficient for Stage III scarring/tracts. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-013", "question": "A 58-year-old man undergoes radical cystectomy with ileal conduit urinary diversion for muscle-invasive bladder cancer. On postoperative day 12, he develops fever, abdominal distension, and elevated white blood cell count. CT scan reveals a 6 cm fluid collection adjacent to the ureteroileal anastomosis with surrounding fat stranding. Percutaneous drainage yields 450 mL of fluid with creatinine level of 18 mg/dL (serum creatinine 1.2 mg/dL). Antegrade nephrostogram demonstrates extravasation at the left ureteroileal anastomosis. The patient is hemodynamically stable. Which management approach is MOST appropriate?", "options": ["Immediate surgical exploration with ureteral reimplantation", "Percutaneous nephrostomy tube placement with continued drainage of urinoma", "Retrograde ureteral stent placement via the ileal conduit", "Endoscopic balloon dilation of the ureteroileal anastomosis", "Conservative management with Foley catheter drainage of the ileal conduit"], "answer": "B", "answer_index": 1, "explanation": "Ureteroileal anastomotic leak in a stable patient is best managed with urinary diversion via percutaneous nephrostomy to decompress the collecting system and allow the anastomosis to heal, combined with drainage of the urinoma. This approach allows most leaks to heal within 4-6 weeks. Immediate surgical exploration in the early postoperative period with inflammation and potential infection carries high morbidity. Retrograde stenting through an ileal conduit is technically challenging and often unsuccessful. Balloon dilation is for strictures, not acute leaks. Simple conduit drainage does not adequately decompress the system proximal to the leak.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with a ureteroileal anastomotic leak (urinoma) 12 days after radical cystectomy, confirmed by elevated fluid creatinine and extravasation on nephrostogram. In a hemodynamically stable patient, the standard of care is maximal urinary diversion to allow the anastomosis to heal, combined with drainage of the collection. Percutaneous nephrostomy (PCN) is the preferred method for proximal diversion in this setting (Option B). Immediate surgical exploration (Option A) is avoided in the early postoperative period due to the 'hostile abdomen' and high morbidity, unless the patient is unstable or minimally invasive measures fail. Retrograde stenting (Option C) is technically challenging and often unfeasible in a fresh ileal conduit due to edema and difficulty locating the ureteral orifices. Balloon dilation (Option D) is indicated for strictures, not acute leaks. Simple conduit drainage (Option E) is insufficient to divert urine away from the anastomotic defect. The item is medically accurate, logically sound, and the key is uniquely defensible.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with a ureteroileal anastomotic leak (urinoma) 12 days after radical cystectomy, confirmed by elevated fluid creatinine and extravasation on nephrostogram. In a hemodynamically stable patient, the standard of care is maximal urinary diversion to allow the anastomosis to heal, combined with drainage of the collection. Percutaneous nephrostomy (PCN) is the preferred method for proximal diversion in this setting (Option B). Immediate surgical exploration (Option A) is avoided in the early postoperative period due to the 'hostile abdomen' and high morbidity, unless the patient is unstable or minimally invasive measures fail. Retrograde stenting (Option C) is technically challenging and often unfeasible in a fresh ileal conduit due to edema and difficulty locating the ureteral orifices. Balloon dilation (Option D) is indicated for strictures, not acute leaks. Simple conduit drainage (Option E) is insufficient to divert urine away from the anastomotic defect. The item is medically accurate, logically sound, and the key is uniquely defensible.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-014", "question": "A 55-year-old woman presents with progressive hearing loss, tinnitus, and imbalance over 2 years. Audiometry reveals asymmetric sensorineural hearing loss with word recognition score of 48% on the right. MRI shows a 2.8 cm right vestibular schwannoma with brainstem compression. She desires hearing preservation if possible. ABR shows prolonged wave I-V interpeak latency. Which treatment approach offers the BEST chance of serviceable hearing preservation while achieving tumor control?", "options": ["Translabyrinthine approach for complete tumor resection", "Retrosigmoid approach with intraoperative auditory monitoring", "Middle fossa approach with facial nerve monitoring", "Gamma Knife stereotactic radiosurgery (12-13 Gy marginal dose)", "Fractionated stereotactic radiotherapy (50.4 Gy in 28 fractions)"], "answer": "E", "answer_index": 4, "explanation": "For vestibular schwannomas >2.5 cm with brainstem compression where hearing preservation is desired, fractionated stereotactic radiotherapy (FSRT) offers superior hearing preservation rates (60-80%) compared to single-fraction radiosurgery (40-50%) while maintaining excellent tumor control. The larger tumor size with brainstem compression makes single-fraction SRS less ideal due to toxicity concerns. Surgical approaches for tumors this size have poor hearing preservation rates (<30%). The translabyrinthine approach sacrifices hearing by design. The middle fossa approach is limited to tumors <1.5 cm in the internal auditory canal. The prolonged ABR suggests cochlear nerve dysfunction making surgical hearing preservation unlikely.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: C (Contradiction). Verdict: No defensible answer. The item is logically flawed due to an internal contradiction regarding the definition of 'serviceable hearing.' The stem describes a patient with a word recognition score (WRS) of 48%. According to standard AAO-HNS guidelines, serviceable hearing is defined as a WRS >50% (and PTA <50 dB). Therefore, the patient currently has non-serviceable hearing, making the question's goal to 'preserve serviceable hearing' impossible. Furthermore, for a 2.8 cm vestibular schwannoma with brainstem compression and poor hearing, the standard of care is typically microsurgical resection (often Translabyrinthine, Option A) to relieve compression and prioritize facial nerve safety, as hearing is already lost. Radiotherapy (Options D/E) for a tumor of this size with brainstem compression carries significant risks of post-treatment expansion and acute worsening of compression. The keyed answer (E) relies on the incorrect premise that the hearing is serviceable and that radiation is the best primary management for a large compressive lesion. Minimal fix: Change WRS to 80% and reduce tumor size to <2.0 cm (or remove brainstem compression) to make FSRT a valid consideration for hearing preservation.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: C (Contradiction). Verdict: No defensible answer. The item is logically flawed due to an internal contradiction regarding the definition of 'serviceable hearing.' The stem describes a patient with a word recognition score (WRS) of 48%. According to standard AAO-HNS guidelines, serviceable hearing is defined as a WRS >50% (and PTA <50 dB). Therefore, the patient currently has non-serviceable hearing, making the question's goal to 'preserve serviceable hearing' impossible. Furthermore, for a 2.8 cm vestibular schwannoma with brainstem compression and poor hearing, the standard of care is typically microsurgical resection (often Translabyrinthine, Option A) to relieve compression and prioritize facial nerve safety, as hearing is already lost. Radiotherapy (Options D/E) for a tumor of this size with brainstem compression carries significant risks of post-treatment expansion and acute worsening of compression. The keyed answer (E) relies on the incorrect premise that the hearing is serviceable and that radiation is the best primary management for a large compressive lesion. Minimal fix: Change WRS to 80% and reduce tumor size to <2.0 cm (or remove brainstem compression) to make FSRT a valid consideration for hearing preservation.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-015", "question": "A 32-year-old man sustains a complete C6 ASIA A spinal cord injury in a motor vehicle accident. At 8 months post-injury, he has developed a 4 cm sacral pressure ulcer extending to bone with undermining. He undergoes successful myocutaneous flap closure. During inpatient rehabilitation, he experiences recurrent episodes of severe headache, flushing above the injury level, and blood pressure elevations to 210/120 mmHg. Bladder scan shows 650 mL. After catheterization, symptoms resolve. Which medication regimen provides the MOST effective prophylaxis against future episodes?", "options": ["Scheduled oxybutynin 5 mg TID with PRN nifedipine for acute episodes", "Prazosin 1 mg TID with scheduled tamsulosin", "Scheduled terazosin 5 mg daily with PRN nitropaste for acute episodes", "Propranolol 20 mg TID with PRN hydralazine", "Clonidine 0.1 mg TID with PRN captopril"], "answer": "C", "answer_index": 2, "explanation": "Autonomic dysreflexia (AD) in spinal cord injury above T6 is most commonly triggered by bladder distension. Prophylaxis focuses on preventing triggers and blocking the sympathetic response. Alpha-1 blockers (terazosin, prazosin) are first-line prophylactic agents as they block the peripheral vasoconstriction causing hypertension. Terazosin's longer half-life allows once-daily dosing. For acute episodes, rapid-acting vasodilators like nitropaste (2% nitroglycerin) or nifedipine are appropriate. Beta-blockers are contraindicated as they can worsen hypertension by blocking beta-2 vasodilation while leaving alpha-mediated vasoconstriction unopposed. Oxybutynin addresses bladder spasticity but not the vascular response.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a classic presentation of Autonomic Dysreflexia (AD) in a patient with a C6 spinal cord injury, triggered by bladder distension. The question asks for the most effective medication regimen for prophylaxis. Current clinical guidelines (e.g., Paralyzed Veterans of America) recommend alpha-adrenergic blockers (such as terazosin or prazosin) as first-line pharmacologic prophylaxis for recurrent AD. These agents block the sympathetic vasoconstriction responsible for the hypertensive crisis and also relax the internal urethral sphincter, addressing the bladder trigger. Option C correctly pairs a standard prophylactic alpha-blocker (Terazosin) with an appropriate acute management agent (Nitropaste). Option A is inferior because immediate-release nifedipine is frequently cautioned against due to the risk of uncontrolled hypotension and stroke, whereas Nitropaste allows for rapid titration/removal. Additionally, while Oxybutynin treats detrusor overactivity, alpha-blockers address the systemic mechanism of AD directly. Option D is incorrect because beta-blockers can leave alpha-adrenergic vasoconstriction unopposed, worsening hypertension. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a classic presentation of Autonomic Dysreflexia (AD) in a patient with a C6 spinal cord injury, triggered by bladder distension. The question asks for the most effective medication regimen for prophylaxis. Current clinical guidelines (e.g., Paralyzed Veterans of America) recommend alpha-adrenergic blockers (such as terazosin or prazosin) as first-line pharmacologic prophylaxis for recurrent AD. These agents block the sympathetic vasoconstriction responsible for the hypertensive crisis and also relax the internal urethral sphincter, addressing the bladder trigger. Option C correctly pairs a standard prophylactic alpha-blocker (Terazosin) with an appropriate acute management agent (Nitropaste). Option A is inferior because immediate-release nifedipine is frequently cautioned against due to the risk of uncontrolled hypotension and stroke, whereas Nitropaste allows for rapid titration/removal. Additionally, while Oxybutynin treats detrusor overactivity, alpha-blockers address the systemic mechanism of AD directly. Option D is incorrect because beta-blockers can leave alpha-adrenergic vasoconstriction unopposed, worsening hypertension. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-016", "question": "A 45-year-old woman undergoes bilateral breast reconstruction with tissue expanders following mastectomy for DCIS. At 6 weeks post-expansion completion, she develops erythema, swelling, and pain of the right breast without fever. Cultures from aspiration grow Mycobacterium fortuitum. The tissue expander is removed and she completes 6 months of appropriate antibiotic therapy with clinical resolution. She now desires completion of reconstruction. Which reconstructive approach carries the LOWEST risk of recurrent infection?", "options": ["Immediate tissue expander replacement with antibiotic irrigation", "Delayed tissue expander placement after 6 months observation", "Autologous reconstruction with pedicled latissimus dorsi flap", "Autologous reconstruction with free DIEP flap", "Direct-to-implant reconstruction with acellular dermal matrix"], "answer": "D", "answer_index": 3, "explanation": "Following nontuberculous mycobacterial (NTM) infection requiring implant removal, autologous reconstruction provides the lowest recurrence risk as it avoids reintroduction of foreign material into a previously infected field. Free tissue transfer (DIEP flap) is preferred over pedicled flaps as it brings well-vascularized tissue from an unaffected donor site without traversing the previously infected chest wall. The latissimus flap, while autologous, requires dissection through potentially contaminated tissue planes. Any implant-based reconstruction (expander or direct-to-implant) carries significant risk of biofilm formation and recurrent NTM infection, even after prolonged antibiotic therapy and observation period.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is medically accurate and logically valid. It addresses the management of Mycobacterium fortuitum (NTM) infection in breast reconstruction, a high-yield board topic. The clinical consensus is that NTM infections are biofilm-forming and difficult to eradicate, making the reintroduction of foreign material (tissue expanders or implants) high risk for recurrence. This effectively rules out options A, B, and E. The decision narrows to the two autologous options: pedicled Latissimus Dorsi (LD) flap (C) vs. free DIEP flap (D). While both are autologous, the DIEP flap is the superior answer for two reasons: 1) It provides sufficient volume for total autologous reconstruction, whereas LD often requires an underlying implant (which would increase infection risk) or yields insufficient volume; and 2) As noted in the rationale, the DIEP flap transfers tissue from a distant, uninfected site without a pedicle traversing the potentially contaminated axillary/chest wall field. The item supports a unique best answer consistent with plastic surgery standards.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is medically accurate and logically valid. It addresses the management of Mycobacterium fortuitum (NTM) infection in breast reconstruction, a high-yield board topic. The clinical consensus is that NTM infections are biofilm-forming and difficult to eradicate, making the reintroduction of foreign material (tissue expanders or implants) high risk for recurrence. This effectively rules out options A, B, and E. The decision narrows to the two autologous options: pedicled Latissimus Dorsi (LD) flap (C) vs. free DIEP flap (D). While both are autologous, the DIEP flap is the superior answer for two reasons: 1) It provides sufficient volume for total autologous reconstruction, whereas LD often requires an underlying implant (which would increase infection risk) or yields insufficient volume; and 2) As noted in the rationale, the DIEP flap transfers tissue from a distant, uninfected site without a pedicle traversing the potentially contaminated axillary/chest wall field. The item supports a unique best answer consistent with plastic surgery standards.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-017", "question": "A 52-year-old woman presents with a 2-year history of progressive gait difficulty and urinary urgency. MRI reveals a 1.8 cm intradural intramedullary lesion at T8 with homogeneous enhancement and associated syrinx extending from T6 to T10. The lesion has well-defined margins and appears to have a cleavage plane from the spinal cord. Intraoperatively, after myelotomy, a grayish-tan tumor is encountered that appears to have a clear plane from the surrounding cord. Frozen section suggests ependymoma. Which surgical strategy is MOST appropriate?", "options": ["Gross total resection with ultrasonic aspiration of tumor margins", "Gross total resection with en bloc removal maintaining tumor capsule integrity", "Subtotal resection followed by adjuvant radiation therapy", "Biopsy only with planned stereotactic radiosurgery", "Gross total resection with intraoperative radiation to tumor bed"], "answer": "B", "answer_index": 1, "explanation": "Spinal cord ependymomas are typically well-circumscribed tumors with a clear cleavage plane from surrounding neural tissue, making gross total resection (GTR) the treatment of choice with excellent long-term outcomes (>90% 10-year PFS with GTR). En bloc removal maintaining capsule integrity is preferred over piecemeal resection to minimize cord manipulation and reduce recurrence risk from residual tumor cells. Ultrasonic aspiration at margins risks thermal injury to the cord and tumor spillage. Subtotal resection with radiation has inferior outcomes to GTR alone. The presence of a clear plane and characteristic appearance strongly supports attempting complete resection.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). Verdict: Keyed answer is the best available option by elimination, though medically flawed. \\n\\nThe vignette describes a classic intramedullary spinal cord ependymoma (T8, syrinx, cleavage plane). The standard of care is Gross Total Resection (GTR). \\n\\nLogical/Medical Issue: The item relies on a medical inaccuracy regarding surgical technique. The key (B) and rationale advocate for 'en bloc' resection to 'minimize cord manipulation.' In standard neurosurgical practice, intramedullary ependymomas are resected via internal debulking (piecemeal) specifically to *avoid* the traction/manipulation required for en bloc removal. En bloc resection is the rule for Hemangioblastomas (to avoid bleeding) or Cauda Equina ependymomas, not thoracic intramedullary ependymomas. However, Option A is incorrect because 'ultrasonic aspiration of tumor margins' is unsafe (CUSA is used centrally; margins are dissected manually). Options C, D, and E are inferior management strategies. \\n\\nThus, B is the only option describing GTR without an explicit safety violation (like CUSA at margins), making it the intended best answer despite the conflation of hemangioblastoma principles. \\n\\nMinimal Fix: Change the diagnosis to 'Hemangioblastoma' (making B fully correct) or change Option B to 'Gross total resection with internal debulking'.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). Verdict: Keyed answer is the best available option by elimination, though medically flawed. \n\nThe vignette describes a classic intramedullary spinal cord ependymoma (T8, syrinx, cleavage plane). The standard of care is Gross Total Resection (GTR). \n\nLogical/Medical Issue: The item relies on a medical inaccuracy regarding surgical technique. The key (B) and rationale advocate for 'en bloc' resection to 'minimize cord manipulation.' In standard neurosurgical practice, intramedullary ependymomas are resected via internal debulking (piecemeal) specifically to *avoid* the traction/manipulation required for en bloc removal. En bloc resection is the rule for Hemangioblastomas (to avoid bleeding) or Cauda Equina ependymomas, not thoracic intramedullary ependymomas. However, Option A is incorrect because 'ultrasonic aspiration of tumor margins' is unsafe (CUSA is used centrally; margins are dissected manually). Options C, D, and E are inferior management strategies. \n\nThus, B is the only option describing GTR without an explicit safety violation (like CUSA at margins), making it the intended best answer despite the conflation of hemangioblastoma principles. \n\nMinimal Fix: Change the diagnosis to 'Hemangioblastoma' (making B fully correct) or change Option B to 'Gross total resection with internal debulking'.", "medical_accuracy_score": 2, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-018", "question": "A 68-year-old man with HPV-positive oropharyngeal squamous cell carcinoma (T2N1M0, p16+) is treated with definitive intensity-modulated radiation therapy (70 Gy in 35 fractions) with concurrent cisplatin. At 3-month follow-up, PET-CT shows complete metabolic response. At 18 months, he develops progressive dysphagia and weight loss. Modified barium swallow reveals severe pharyngeal dysmotility with aspiration. Direct laryngoscopy shows no tumor recurrence but severe pharyngeal fibrosis with reduced epiglottic deflection. Which factor during his initial treatment MOST strongly predicts this complication?", "options": ["Mean dose to the superior pharyngeal constrictor muscle >60 Gy", "Maximum dose to the larynx >70 Gy", "Mean dose to the parotid glands >26 Gy", "Volume of oral cavity receiving >40 Gy", "Mean dose to the cervical esophagus >45 Gy"], "answer": "A", "answer_index": 0, "explanation": "Severe late dysphagia with pharyngeal dysmotility following head and neck radiation is most strongly associated with dose to the pharyngeal constrictor muscles, particularly the superior and middle constrictors. The QUANTEC guidelines and subsequent studies identify mean pharyngeal constrictor dose >60 Gy as a significant predictor of severe dysphagia. Modern IMRT planning prioritizes constrictor sparing when oncologically feasible. While laryngeal dose affects aspiration risk and parotid dose affects xerostomia, the described pattern of pharyngeal dysmotility with reduced epiglottic deflection specifically implicates constrictor muscle fibrosis. Esophageal dose correlates more with stricture than dysmotility.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item describes a classic presentation of late radiation-associated dysphagia (RAD) characterized by pharyngeal fibrosis and dysmotility. The clinical findings (severe pharyngeal dysmotility, reduced epiglottic deflection, aspiration) point specifically to damage of the pharyngeal constrictor muscles (PCM) rather than laryngeal edema or esophageal stricture. Extensive literature (e.g., QUANTEC, Christianen et al.) identifies the mean dose to the pharyngeal constrictors as the most significant predictor of long-term dysphagia. A mean dose >60 Gy to the superior pharyngeal constrictor (Option A) is a well-documented threshold for high risk of severe late dysphagia; modern planning aims to keep this mean dose <5055 Gy when feasible. Option B (larynx dose) contributes to aspiration but is less specific to the dysmotility mechanism described. Option C predicts xerostomia. Option E predicts esophageal stricture. The question is medically accurate, aligns with standard radiation oncology guidelines, and possesses a unique, defensible best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item describes a classic presentation of late radiation-associated dysphagia (RAD) characterized by pharyngeal fibrosis and dysmotility. The clinical findings (severe pharyngeal dysmotility, reduced epiglottic deflection, aspiration) point specifically to damage of the pharyngeal constrictor muscles (PCM) rather than laryngeal edema or esophageal stricture. Extensive literature (e.g., QUANTEC, Christianen et al.) identifies the mean dose to the pharyngeal constrictors as the most significant predictor of long-term dysphagia. A mean dose >60 Gy to the superior pharyngeal constrictor (Option A) is a well-documented threshold for high risk of severe late dysphagia; modern planning aims to keep this mean dose <5055 Gy when feasible. Option B (larynx dose) contributes to aspiration but is less specific to the dysmotility mechanism described. Option C predicts xerostomia. Option E predicts esophageal stricture. The question is medically accurate, aligns with standard radiation oncology guidelines, and possesses a unique, defensible best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-019", "question": "A 63-year-old man undergoes right upper lobectomy via video-assisted thoracoscopic surgery (VATS) for a 2.5 cm adenocarcinoma. On postoperative day 3, chest tube output increases to 800 mL of milky fluid over 24 hours. Pleural fluid triglycerides are 380 mg/dL and chylomicrons are present. He is started on NPO with total parenteral nutrition. After 7 days, output remains 500-600 mL daily. Lymphangiography shows the leak originating from the thoracic duct at the T10 level. Which intervention is MOST appropriate?", "options": ["Continue conservative management for an additional 7 days", "Thoracic duct embolization via percutaneous approach", "VATS thoracic duct ligation at the level of the leak", "Right thoracotomy with mass ligation of thoracic duct at the diaphragmatic hiatus", "Pleurodesis with talc slurry via chest tube"], "answer": "B", "answer_index": 1, "explanation": "Chylothorax following pulmonary resection that persists beyond 5-7 days of conservative management (NPO/TPN or medium-chain triglyceride diet) with output >500 mL/day warrants intervention. Thoracic duct embolization (TDE) has emerged as the first-line interventional approach with success rates of 70-90% and lower morbidity than surgical ligation. The lymphangiography has already localized the leak, facilitating embolization. Surgical ligation is reserved for TDE failure. Mass ligation at the diaphragmatic hiatus is effective but more invasive. Continued conservative management beyond 2 weeks risks malnutrition and immunocompromise. Pleurodesis does not address the underlying leak and has poor success for high-output chylothorax.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a persistent high-output chylothorax (>500 mL/day) following pulmonary resection, which has failed to resolve after 7 days of optimal conservative management (NPO/TPN). Current guidelines generally recommend intervention for chylothorax persisting beyond 57 days with outputs >500 mL/day to prevent malnutrition and immunosuppression. Thoracic duct embolization (TDE) is the preferred first-line intervention over surgical ligation due to its minimally invasive nature and high success rates (7090%). The stem notes that lymphangiography has already visualized the leak, which confirms the feasibility of proceeding directly to embolization. Surgical ligation (VATS or thoracotomy) is typically reserved for cases where TDE fails or is technically impossible. Pleurodesis is rarely effective for high-output leaks (>500 mL/day). Continuing conservative management is inappropriate given the lack of improvement and high volume. The item is medically accurate, follows standard management algorithms, and the key is uniquely defensible.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a persistent high-output chylothorax (>500 mL/day) following pulmonary resection, which has failed to resolve after 7 days of optimal conservative management (NPO/TPN). Current guidelines generally recommend intervention for chylothorax persisting beyond 57 days with outputs >500 mL/day to prevent malnutrition and immunosuppression. Thoracic duct embolization (TDE) is the preferred first-line intervention over surgical ligation due to its minimally invasive nature and high success rates (7090%). The stem notes that lymphangiography has already visualized the leak, which confirms the feasibility of proceeding directly to embolization. Surgical ligation (VATS or thoracotomy) is typically reserved for cases where TDE fails or is technically impossible. Pleurodesis is rarely effective for high-output leaks (>500 mL/day). Continuing conservative management is inappropriate given the lack of improvement and high volume. The item is medically accurate, follows standard management algorithms, and the key is uniquely defensible.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-020", "question": "A 72-year-old man with a history of open infrarenal AAA repair 15 years ago presents with melena and hemoglobin of 6.8 g/dL. Upper endoscopy reveals a pulsatile mass eroding into the third portion of the duodenum with adherent clot. CT angiography confirms an aortoenteric fistula at the proximal anastomosis with a 4 cm pseudoaneurysm. He is hemodynamically stabilized with transfusion. Which definitive management strategy offers the BEST balance of durability and survival?", "options": ["Endovascular aortic stent graft placement with duodenal repair", "Extra-anatomic axillobifemoral bypass with graft excision and aortic stump closure", "In-situ reconstruction with cryopreserved aortic allograft after graft excision", "In-situ reconstruction with rifampin-soaked Dacron graft and omental wrap", "Endovascular stent graft as bridge to delayed open reconstruction"], "answer": "C", "answer_index": 2, "explanation": "Aortoenteric fistula (AEF) is a life-threatening complication requiring definitive surgical management. In-situ reconstruction with cryopreserved aortic allograft provides the best combination of infection resistance and durability, with lower reinfection rates (5-10%) compared to prosthetic grafts (20-30%) and better long-term patency than extra-anatomic bypass. Extra-anatomic bypass has high rates of aortic stump blowout and graft thrombosis. Endovascular repair alone does not address the infected field and has high failure rates for AEF. Rifampin-soaked Dacron has higher reinfection rates than allograft in this contaminated setting. The duodenum must also be repaired or resected with the definitive procedure.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question describes a secondary aortoenteric fistula (SAEF) in a hemodynamically stable patient. The clinical task is to identify the best definitive surgical management. Current vascular surgery consensus favors in-situ reconstruction (ISR) over extra-anatomic bypass (Option B) due to superior patency and the avoidance of aortic stump blowout, which carries high mortality. Among ISR options, biological conduits (femoral vein or cryopreserved allograft) are preferred over synthetic grafts (Option D) in the presence of gross enteric contamination due to lower reinfection rates. Since the 'gold standard' femoral vein (NAIS) is not an option, cryopreserved allograft (Option C) is the most appropriate remaining choice for definitive repair in a contaminated field. EVAR (Options A and E) leaves the infected graft and fistula tract in place, serving primarily as a bridge to surgery or palliation in unfit patients, not definitive cure. The question is well-constructed, the distractors represent real but inferior or outdated strategies, and the key reflects standard board-level management principles.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question describes a secondary aortoenteric fistula (SAEF) in a hemodynamically stable patient. The clinical task is to identify the best definitive surgical management. Current vascular surgery consensus favors in-situ reconstruction (ISR) over extra-anatomic bypass (Option B) due to superior patency and the avoidance of aortic stump blowout, which carries high mortality. Among ISR options, biological conduits (femoral vein or cryopreserved allograft) are preferred over synthetic grafts (Option D) in the presence of gross enteric contamination due to lower reinfection rates. Since the 'gold standard' femoral vein (NAIS) is not an option, cryopreserved allograft (Option C) is the most appropriate remaining choice for definitive repair in a contaminated field. EVAR (Options A and E) leaves the infected graft and fistula tract in place, serving primarily as a bridge to surgery or palliation in unfit patients, not definitive cure. The question is well-constructed, the distractors represent real but inferior or outdated strategies, and the key reflects standard board-level management principles.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]